IL95235A - חלבון pg031 ותהליך להכנתו - Google Patents
חלבון pg031 ותהליך להכנתוInfo
- Publication number
- IL95235A IL95235A IL9523590A IL9523590A IL95235A IL 95235 A IL95235 A IL 95235A IL 9523590 A IL9523590 A IL 9523590A IL 9523590 A IL9523590 A IL 9523590A IL 95235 A IL95235 A IL 95235A
- Authority
- IL
- Israel
- Prior art keywords
- protein
- receptor
- human
- cells
- dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20023089 | 1989-08-03 | ||
JP2140069A JP2898064B2 (ja) | 1989-08-03 | 1990-05-31 | ヒトgp130蛋白質 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL95235A0 IL95235A0 (en) | 1991-06-10 |
IL95235A true IL95235A (he) | 1995-11-27 |
Family
ID=26472699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9523590A IL95235A (he) | 1989-08-03 | 1990-07-30 | חלבון pg031 ותהליך להכנתו |
Country Status (10)
Country | Link |
---|---|
US (1) | US5132403A (he) |
EP (1) | EP0411946B1 (he) |
JP (1) | JP2898064B2 (he) |
KR (1) | KR0178384B1 (he) |
AT (1) | ATE147099T1 (he) |
AU (1) | AU635296B2 (he) |
CA (1) | CA2022610C (he) |
DE (1) | DE69029545T2 (he) |
ES (1) | ES2096580T3 (he) |
IL (1) | IL95235A (he) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5262522A (en) * | 1991-11-22 | 1993-11-16 | Immunex Corporation | Receptor for oncostatin M and leukemia inhibitory factor |
ES2215359T3 (es) * | 1991-12-18 | 2004-10-01 | Icu Medical, Inc. | Procedimiento de transferencia de fluido. |
JPH05304986A (ja) * | 1992-04-28 | 1993-11-19 | Tosoh Corp | gp130蛋白質に対するモノクロ−ナル抗体 |
IT1261787B (it) * | 1993-06-23 | 1996-06-03 | Angeletti P Ist Richerche Bio | Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130. |
US5789552A (en) * | 1993-06-23 | 1998-08-04 | Istituto Di Ricerche Di Biologica Molecolare P. Angeletti S.P.A. | Interleukin-6 receptor antagonists |
US5783672A (en) | 1994-05-26 | 1998-07-21 | Immunex Corporation | Receptor for oncostatin M |
US5952748A (en) * | 1994-06-23 | 1999-09-14 | Elin Motoren Gmbh | High speed motor with two-phase cooling system |
GB9419021D0 (en) * | 1994-09-21 | 1994-11-09 | Applied Research Systems | Therapeutic protein |
DK0783893T3 (da) | 1994-10-07 | 2012-05-29 | Chugai Pharmaceutical Co Ltd | Inhibering af unormal vækst af synovial-celler under anvendelse af il-6-antagonist som aktiv bestanddel |
JP3458512B2 (ja) | 1995-02-23 | 2003-10-20 | 東ソー株式会社 | 骨密度の変動推定方法又は骨そしょう症の診断方法及びこれに用いる試薬キット |
US5674995A (en) * | 1995-06-07 | 1997-10-07 | Gen-Probe Incorporated | Oligonucleotides specific for cytokine signal transducer gp130 mRNA |
CA2222520A1 (en) * | 1995-06-07 | 1996-12-19 | Yathi M. Naidu | Oligonucleotides specific for cytokine signal transducer gp130 mrna |
US5747470A (en) * | 1995-06-07 | 1998-05-05 | Gen-Probe Incorporated | Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA |
AU723057B2 (en) * | 1995-11-07 | 2000-08-17 | Kaneka Corporation | Autoantigen |
AU736282B2 (en) | 1997-03-21 | 2001-07-26 | Chugai Seiyaku Kabushiki Kaisha | A preventive or therapeutic agent for sensitized T cell- mediated diseases comprising IL-6 antagonist as an active ingredient |
EP2135953B1 (en) | 1999-06-02 | 2014-04-23 | Chugai Seiyaku Kabushiki Kaisha | Novel hemopoietin receptor protein, Nr. 10 |
AU7078200A (en) * | 1999-08-27 | 2001-03-26 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Polypeptides, comprising il-6 ligand-binding receptor domains and related nucleic acids, antibodies, compositions, and methods of use |
ES2254224T3 (es) | 1999-09-27 | 2006-06-16 | Chugai Seiyaku Kabushiki Kaisha | Nueva proteina del receptor de hematopoyetina, nr12. |
US7175988B2 (en) * | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
UA80091C2 (en) | 2001-04-02 | 2007-08-27 | Chugai Pharmaceutical Co Ltd | Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist |
GB0210539D0 (en) * | 2002-05-08 | 2002-06-19 | Univ Edinburgh | Control of es cell self renewal and lineage specification, and medium therefor |
GB2401040A (en) | 2003-04-28 | 2004-11-03 | Chugai Pharmaceutical Co Ltd | Method for treating interleukin-6 related diseases |
AR061400A1 (es) | 2005-10-14 | 2008-08-27 | Chugai Kabushiki Kaisha | Agentes para suprimir el dano a los islotes transplantados despues del transplante de islotes |
JP4837358B2 (ja) * | 2005-10-19 | 2011-12-14 | 株式会社野村工電社 | ボトル飲用水充填装置 |
AU2006305119B2 (en) | 2005-10-21 | 2012-12-20 | Chugai Seiyaku Kabushiki Kaisha | Agents for treating cardiopathy |
AR057582A1 (es) | 2005-11-15 | 2007-12-05 | Nat Hospital Organization | Agentes para suprimir la induccion de linfocitos t citotoxicos |
AR057941A1 (es) | 2005-11-25 | 2007-12-26 | Univ Keio | Agentes terapeuticos para el cancer de prostata |
CN101370521A (zh) | 2006-01-27 | 2009-02-18 | 学校法人庆应义塾 | 伴有脉络膜血管生成的疾病的治疗药 |
WO2007116962A1 (ja) | 2006-04-07 | 2007-10-18 | Osaka University | 筋再生促進剤 |
UA100116C2 (ru) | 2006-06-08 | 2012-11-26 | Чугей Сейяку Кабусики Кайся | Профилактика или лечение воспалительного заболевания |
US8629244B2 (en) | 2006-08-18 | 2014-01-14 | Ablynx N.V. | Interleukin-6 receptor binding polypeptides |
RU2450829C2 (ru) | 2007-01-23 | 2012-05-20 | Синсу Юниверсити | Ингибитор хронического отторжения |
US20080283557A1 (en) * | 2007-05-17 | 2008-11-20 | Julianne Desautels | Spout for food stuff container |
TWI441649B (zh) | 2007-12-05 | 2014-06-21 | Chugai Pharmaceutical Co Ltd | Use of anti-NR10 monoclonal antibody with neutralizing activity against NR10 in the manufacture of prophylactic or therapeutic agents for pruritus |
US10717781B2 (en) | 2008-06-05 | 2020-07-21 | National Cancer Center | Neuroinvasion inhibitor |
EP2226633A1 (en) | 2009-03-06 | 2010-09-08 | Charité - Universitätsmedizin Berlin | Uses and methods for the identification of a cytoprotective compound involving gp130 or LIFRalpha |
EP2417163B1 (en) | 2009-04-10 | 2019-02-27 | Ablynx N.V. | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders |
US10618964B2 (en) | 2009-04-10 | 2020-04-14 | Ablynx N.V. | Nanobody against IL-6R |
EP2578233B1 (en) | 2010-05-28 | 2017-04-26 | National Cancer Center | Therapeutic agent for pancreatic cancer |
ES2932398T3 (es) | 2010-05-28 | 2023-01-18 | Chugai Pharmaceutical Co Ltd | Potenciador de la respuesta de las células T antitumorales |
US10138302B2 (en) | 2011-09-23 | 2018-11-27 | Ablynx N.V. | Methods for treating rheumatoid arthritis by administering interleukin-6 receptor antibodies |
WO2014200018A1 (ja) | 2013-06-11 | 2014-12-18 | 独立行政法人 国立精神・神経医療研究センター | 再発寛解型多発性硬化症(rrms)患者の治療予後予測方法、及び新規治療適応判断方法 |
CN107074954A (zh) | 2014-10-21 | 2017-08-18 | 埃博灵克斯股份有限公司 | Il‑6r相关疾病的治疗 |
KR101892883B1 (ko) | 2015-02-27 | 2018-10-05 | 추가이 세이야쿠 가부시키가이샤 | Il-6 관련 질환 치료용 조성물 |
WO2018203545A1 (ja) | 2017-05-02 | 2018-11-08 | 国立研究開発法人国立精神・神経医療研究センター | Il-6及び好中球の関連する疾患の治療効果の予測及び判定方法 |
EP3747469A4 (en) | 2018-01-31 | 2022-03-23 | Motokazu Kato | THERAPEUTIC AGENT FOR ASTHMA CONTAINING AN IL-6 INHIBITOR |
MX2021012163A (es) | 2019-04-17 | 2022-01-31 | Univ Hiroshima | Agente terapeutico para cancer urologico que se caracteriza por ser administrado con un inhibidor de il-6 y un inhibidor de ccr2 en combinacion. |
KR102416078B1 (ko) | 2019-11-20 | 2022-07-01 | 추가이 세이야쿠 가부시키가이샤 | 항체 함유 제제 |
KR102351174B1 (ko) * | 2020-05-11 | 2022-01-14 | (주)아이테오솔루션즈 | 랜 포트의 혼동을 방지하는 어댑터 및 이를 포함하는 랜 포트 보안 장치 |
JP2023553694A (ja) | 2020-12-18 | 2023-12-25 | アブリンクス エン.ヴェー. | IL-6およびTNF-αを標的化する免疫グロブリン単一可変ドメインを含むポリペプチド |
-
1990
- 1990-05-31 JP JP2140069A patent/JP2898064B2/ja not_active Expired - Lifetime
- 1990-07-30 IL IL9523590A patent/IL95235A/he active IP Right Grant
- 1990-07-31 AU AU60039/90A patent/AU635296B2/en not_active Expired
- 1990-08-01 KR KR1019900011808A patent/KR0178384B1/ko not_active IP Right Cessation
- 1990-08-02 CA CA002022610A patent/CA2022610C/en not_active Expired - Lifetime
- 1990-08-02 DE DE69029545T patent/DE69029545T2/de not_active Expired - Lifetime
- 1990-08-02 EP EP90308530A patent/EP0411946B1/en not_active Expired - Lifetime
- 1990-08-02 AT AT90308530T patent/ATE147099T1/de not_active IP Right Cessation
- 1990-08-02 ES ES90308530T patent/ES2096580T3/es not_active Expired - Lifetime
- 1990-08-02 US US07/561,564 patent/US5132403A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5132403A (en) | 1992-07-21 |
KR910004801A (ko) | 1991-03-29 |
AU6003990A (en) | 1991-02-07 |
EP0411946B1 (en) | 1997-01-02 |
JPH0429997A (ja) | 1992-01-31 |
CA2022610C (en) | 2001-01-30 |
EP0411946A2 (en) | 1991-02-06 |
IL95235A0 (en) | 1991-06-10 |
DE69029545D1 (de) | 1997-02-13 |
JP2898064B2 (ja) | 1999-05-31 |
EP0411946A3 (en) | 1992-02-12 |
ATE147099T1 (de) | 1997-01-15 |
DE69029545T2 (de) | 1997-07-24 |
ES2096580T3 (es) | 1997-03-16 |
CA2022610A1 (en) | 1991-02-04 |
KR0178384B1 (ko) | 1999-04-01 |
AU635296B2 (en) | 1993-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5132403A (en) | Human gp130 protein | |
CA2021594C (en) | Antibody to human interleukin-6 receptor | |
JP2866706B2 (ja) | 腫瘍壊死因子結合蛋白 | |
KR0144861B1 (ko) | 인간 b세포 자극인자-2에 대한 수용체 단백질 | |
US5670373A (en) | Antibody to human interleukin-6 receptor | |
US7211259B1 (en) | 4-1BB polypeptides and DNA encoding 4-1BB polypeptides | |
EP0760857B9 (en) | Receptor for oncostatin m | |
JP3255699B2 (ja) | ヒトIL−2レセプターγ鎖分子 | |
Khamlichi et al. | Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients | |
JPH04164099A (ja) | Tnf結合タンパク質 | |
JP2898040B2 (ja) | gp130蛋白質に対する抗体 | |
KR20040075105A (ko) | 인터페론 α 활성을 선택적으로 차단하는 인터페론α/β수용체에 대한 항체 | |
IE903467A1 (en) | Granulocyte-colony stimulating factor receptors | |
US5821078A (en) | Nucleic acid encoding interferon-α/β binding protein | |
US5223611A (en) | DNA encoding for human GP130 protein | |
US5358867A (en) | DNA cloning and expression of an L7 protein which modulates the 2'-5' oligosynthetase and H2-K*K response to type-I interferon | |
KR100382628B1 (ko) | 인터페론α/β결합단백질과이의제조및용도 | |
CA2071622A1 (en) | Anti-tcf-ii monoclonal antibodies and method for the measurement of tcf-ii by applying the antibodies | |
EP0265847B1 (en) | Monoclonal antibody reacting with TRF (interleukin-5) | |
IE902930A1 (en) | Human gp130 protein | |
Chapot et al. | A monoclonal antibody directed against the β1-adrenergic receptor from turkey erythrocyte membranes | |
KR100255331B1 (ko) | 인간 b세포 자극인자-2에 대한 수용체 단백질에 특이적인 항체 및 이를 생산하는 하이브리도마 | |
CA2210683A1 (en) | Anti-tpo monoclonal antibodies | |
JPH05244990A (ja) | ラットil−1抗体及びラットil−1の測定法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |